Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service thrombectomy, IVC filters & venous stents cases in Pennsylvania: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 9% on average (194 state-years, 2020–2024): read it as a direction with a margin.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 15 | 1,846 | 47% |
| 2020 | 9 | 1,755 | 49% |
| 2021 | 14 | 1,917 | 51% |
| 2022 | 13 | 1,975 | 53% |
| 2023 | 10 | 1,890 | 56% |
| 2024 | 14 | 1,998 | 58% |
| 2025 from claims | – | 2,009 1,844–2,126 | 59% |
| 2026 forecast | – | 2,089 1,838–2,410 | 59% |
| 2027 forecast | – | 2,143 1,832–2,553 | 59% |
| 2028 forecast | – | 2,197 1,834–2,691 | 60% |
| 2029 forecast | – | 2,253 1,840–2,826 | 60% |
| 2030 forecast | – | 2,310 1,851–2,960 | 61% |
Mechanical thrombectomy, IVC filter placement, and iliac venous stenting. Professional codes (what the surgeon bills): CPT 37187, 37184, 37191, 37238.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 78% of the cases CMS names in Pennsylvania; 11 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 87% inpatient hospital, 4% hospital outpatient, 9% office.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| New York | 24 | 2,696−2.3%/yr | −2.3%/yr | 1.5 | 17% | 3,720 in 2030+5.5%/yr |
| New Jersey | 25 | 1,782+1%/yr | +1%/yr | 1.7 | 28% | 1,690 in 2030−0.8%/yr |
| Massachusetts | 2 | 738−0.4%/yr | −0.4%/yr | 0.8 | 9% | 740 in 2030+0.1%/yr |
| Connecticut | 1 | 474−5.9%/yr | −5.9%/yr | 1.4 | 23% | 420 in 2030−1.9%/yr |
| New Hampshire | 0 | 145−3.6%/yr | −3.6%/yr | 0.6 | 0% | 220 in 2030+7.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 59 | 4,916−14%/yr | −14%/yr | 3.80.6× | 50% | 4,300 in 2030−2.2%/yr |
| Peripheral arterial intervention | 34 | 4,796−11%/yr | −11%/yr | 3.30.6× | 15% | 4,870 in 2030+0.3%/yr |
| Superficial venous ablation | 45 | 3,315−8.9%/yr | −8.9%/yr | 2.30.6× | 87% | 3,220 in 2030−0.5%/yr |
| Carotid revascularization | 23 | 1,666−3.1%/yr | −3.1%/yr | 1.21.3× | 0% | 1,760 in 2030+0.9%/yr |
| Aortic endografts (EVAR/TEVAR) | 1 | 705−5.5%/yr | −5.5%/yr | 0.51.3× | 0% | 710 in 2030+0.1%/yr |
Thrombectomy, IVC filters & venous stents in every state, and its device makers · Every procedure market in Pennsylvania · Every state · Compare with New York
Stryker leads with 66% of company spending on these surgeons in 2025, −12 pts on 2024.
In 2025, 15 companies reported engagement with Pennsylvania’s surgeons worth $502K in consulting, speaking, meals and travel tied to these products, about $36K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 22 clearances and approvals in the category, 3 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.